Table 1.
Clinical and demographic data for the study group.
| Patients' number (%) | p | ||
|---|---|---|---|
| Gender | Men | 27 (30.7%) | |
| Women | 61 (69.3%) | 0.000 | |
|
| |||
| Location | Urban | 51 (59.3%) | |
| Rural | 35 (40.7%) | .054 | |
|
| |||
| Hypertension | Stage 1 | 16 (18.28%) | .002a |
| Stage 2 | 42 (47.72%) | .03b | |
| Stage 3 | 30 (34%) | .000c | |
|
| |||
| Additional CV risk | Very high | 33 (38.4%) | .04d |
| High | 38 (44.2%) | .000e | |
| Moderate | 15 (17.4%) | .002f | |
|
| |||
| Controlled hypertension | No | 30 (34.5%) | |
| Yes | 57 (65.5%) | .000g | |
|
| |||
| Dyslipidemia | Without | 8 (9.3%) | |
| Hypercholesterolemia | 46 (53.5%) | ||
| Mixed | 27 (31.4%) | ||
| Hypertriglyceridemia | 5 (5.8%) | ||
|
| |||
| Smoking | No | 67 (77.9%) | |
| Yes | 19 (22.1%) | .001g | |
|
| |||
| Weight status | Normal | 34 (39.5%) | .04h |
| Overweight | 31 (27%) | .45i | |
| Obese | 21 (24.4%) | .03j | |
|
| |||
| Diabetes | Absent | 56 (65.1%) | |
| Present | 30 (34.9%) | .001k | |
aStage 1 versus stage 2; bstage 2 versus stage 3; cstage 1 versus stage 3; dvery high versus high; ehigh versus moderate; fvery high versus moderate; gno versus yes; hnormal versus overweight; ioverweight versus obese; jnormal versus obese; kpresent versus absent. CV: cardiovascular.